Mitsubishi UFJ Trust & Banking
BIO icon

Mitsubishi UFJ Trust & Banking’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-894
Closed -$251K – 1099
2025
Q3 		$251K Buy
+894
New +$243K ﹤0.01% 1043
2025
Q2 		– Sell
-8,187
Closed -$1.99M – 1057
2025
Q1 		$1.99M Buy
8,187
+26
+0.3% +$7.82K 0.01% 802
2024
Q4 		$2.68M Sell
8,161
-1,416
-15% -$481K 0.01% 788
2024
Q3 		$3.2M Buy
9,577
+606
+7% +$192K 0.01% 771
2024
Q2 		$2.45M Sell
8,971
-1,494
-14% -$435K 0.01% 770
2024
Q1 		$3.62M Sell
10,465
-1,206
-10% -$397K 0.01% 724
2023
Q4 		$3.77M Sell
11,671
-511
-4% -$160K 0.01% 715
2023
Q3 		$4.37M Sell
12,182
-1,032
-8% -$398K 0.01% 702
2023
Q2 		$5.01M Sell
13,214
-140
-1% -$57K 0.01% 692
2023
Q1 		$6.4M Buy
13,354
+561
+4% +$263K 0.02% 637
2022
Q4 		$5.38M Sell
12,793
-1,913
-13% -$772K 0.01% 665
2022
Q3 		$6.13M Sell
14,706
-443
-3% -$221K 0.02% 622
2022
Q2 		$7.5M Buy
15,149
+15
+0.1% +$7.81K 0.02% 613
2022
Q1 		$8.52M Sell
15,134
-1,559
-9% -$940K 0.02% 605
2021
Q4 		$12.6M Buy
16,693
+147
+0.9% +$110K 0.03% 544
2021
Q3 		$12.3M Buy
16,546
+279
+2% +$209K 0.03% 545
2021
Q2 		$10.5M Buy
16,267
+131
+0.8% +$79.7K 0.02% 605
2021
Q1 		$9.22M Sell
16,136
-2,119
-12% -$1.25M 0.02% 618
2020
Q4 		$10.6M Sell
18,255
-1,228
-6% -$699K 0.02% 614
2020
Q3 		$10M Buy
19,483
+480
+3% +$243K 0.02% 561
2020
Q2 		$8.58M Sell
19,003
-11,178
-37% -$4.93M 0.02% 588
2020
Q1 		$10.6M Buy
30,181
+13,837
+85% +$5.09M 0.03% 475
2019
Q4 		$6.05M Buy
+16,344
New +$5.76M 0.01% 713

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's BIO Position: Q4 2025 in Review

Mitsubishi UFJ Trust & Banking sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 894 shares — an estimated $251K sold.

Mitsubishi UFJ Trust & Banking first reported a position in BIO in Q4 2019 and held it in 23 quarters. The position peaked at $12.6M in Q4 2021. 399 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

  • Mitsubishi UFJ Trust & Banking reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 894 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $251K.
  • Mitsubishi UFJ Trust & Banking first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 23 quarters.
  • Mitsubishi UFJ Trust & Banking's Bio-Rad Laboratories Class A position peaked at $12.6M in Q4 2021.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q4 2025, filed 30 Jan 2026.